About Ascensia Diabetes Care
Established in 2016 through the acquisition of Bayer Diabetes Care by PHC Holdings (formerly known as Panasonic Healthcare Holdings), Ascensia Diabetes Care is a global company dedicated to improving the health and lives of people with diabetes.
Headquartered in Basel, Switzerland, Ascensia has more than 80 years history of helping people manage their diabetes. Our products are available in more than 90 countries worldwide.
We are home to the world renowned CONTOUR® portfolio of blood glucose monitoring systems. We are committed to adding more innovative and life-changing products to our portfolio.
Our approach
Our goal is to provide products and solutions that make a positive, daily difference for people with diabetes. We want to make sure diabetes doesn't get in the way of people's future, enabling them to live richer lives.
Why CONTOUR® meter systems?
Our range of products combines state-of-the-art technology with user-friendly functionality that supports diabetes management, providing clear and accurate readings you can trust.
Through our technology we look to make diabetes management as simple as possible to get the data you need to make informed decisions, and provide systems that make monitoring easier and well-suited to modern living.
Ascensia Diabetes Care In Australia
Continuous research has allowed our team to lead the way in the development of blood glucose monitoring technology and systems. These innovations have been designed to not only meet the needs of patients, but to help simplify and improve their lives.
In November 2024, Ascensia Diabetes Care became the sponsor and distributor of selected Owen Mumford diabetes products, including Unifine Pentips, Unifine Pentips Plus, Unifine SafeControl and Unistik 3. This partnership brings together decades of shared experience in diabetes care and strengthens our commitment to supporting people living with diabetes in Australia.
-
January: Transitioned to coloured
MICROLET® Lancets
2025
-
November: Distribution of selected Owen Mumford diabetes products commenced
2024
-
September: Launched GLUCOCONTRO.ONLINE diabetes data management platform for use by both healthcare professionals and people with diabetes
2022
-
June: Launched the CONTOUR®NEXT button battery compliant connected blood glucose meter
2022
-
June: Launched the CONTOUR®NEXT connected blood glucose meter
2020
-
December: MICROLET® lancets launched commercially
2018
-
August: Launched CONTOUR®NEXT ONE, a Bluetooth® enabled meter with smartLIGHT technology that connects to the newly launched CONTOUR®DIABETES App
2018
-
August: Launched the CONTOUR®NEXT blood glucose meter
2016
-
January: Ascensia Diabetes Care Australia was established in Sydney
2016
-
Ascensia Diabetes Care was established through the sale of Bayer Diabetes Care to Panasonic Healthcare Holdings Co.,Ltd
2016
-
Introduced the CONTOUR®NEXT LINK 2.4 blood glucose meter - jointly designed with Medtronic for use with compatible MiniMed® insulin pumps
2015
To learn about the global history of Ascensia Diabetes Care, and more than 80 years of innovation, visit:
https://www.ascensia.com/about-us/history/
